Signup Crypto ETF Stocks News

SKEL fjárfestingafélag hf.: SKEL sells 15.4% equity stake in Styrkás for ISK 3.15 billion to institutional investors

SKEL has signed purchase agreements with a group of domestic institutional investors for their acquisition of 153.9 million shares in Styrkás hf., representing just over 15.4% of the company's issued share capital. The total purchase price of the shares is ISK 3,150 million, equivalent to ISK ...

Source: www.globenewswire.com
June 06, 2025 | 19:32:00
Category: News

Why Palantir Stock Is Jumping Today

Palantir Technologies ( NASDAQ: PLTR ) stock is surging Friday. The software specialist's share price was up 6.3% as of 3:20 p.m. ET. At the same point in the day's trading, the S&P 500 ( SNPINDEX: ^GSPC ) and Nasdaq Composite ( NASDAQINDEX: ^IXIC ) were up 1.1% and 1.3%, respectively.After ...

Source: www.fool.com
June 06, 2025 | 19:34:38
Category: News

JPMorgan Lifts Acadia Price Target After Nuplazid Patent Victory - ACADIA Pharmaceuticals ( NASDAQ:ACAD )

Court ruling secures Nuplazid's 34 mg formulation patent protection through 2038. JPMorgan hikes Acadia target from $26 to $30, citing strong patent outlook. Get access to the leaderboards pointing to tomorrow's biggest stock movers. In May, the U.S.

Source: www.benzinga.com
June 06, 2025 | 19:34:55
Category: General

Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta - Baker Hughes ( NASDAQ:BKR ) , Blueprint Medicines ( NASDAQ:BPMC )

PatientPoint, Infucare and Moonlake Immunotherapeutics are up for sale. Alex Jones may see his personal assets - including guns, cars, and homes - sold by the end of the year. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here.

Source: www.benzinga.com
June 06, 2025 | 19:37:15
Category: Mergers

Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm - Doximity ( NYSE:DOCS )

NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. DOCS breached their fiduciary duties to shareholders.

Source: www.benzinga.com
June 06, 2025 | 19:45:56
Category: News

OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Organon ( NYSE:OGN )

NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. ( "Organon" or "the Company" ) OGN and certain of its officers.

Source: www.benzinga.com
June 06, 2025 | 20:00:00
Category: News

Northann Corp. Issues Statement on Recent Stock Volatility

Fort Lawn, SC, June 06, 2025 ( GLOBE NEWSWIRE ) -- Northann Corp. ( "Northann" or the "Company" ) ( NYSE American: NCL ) , a company specializing in 3D printing and manufacturing solutions, today announced that it is not aware of any new material developments or pending announcements concerning ...

Source: www.globenewswire.com
June 06, 2025 | 20:00:00
Category: News

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Company announcement - No. ...

Source: www.globenewswire.com
June 06, 2025 | 20:00:00
Category: News

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to July 9, 2025

New York, NY , June 06, 2025 ( GLOBE NEWSWIRE ) -- Globalink Investment Inc. ( OTC Pink: GLLI, GLLIW, GLLIR, GLLIU ) ( "Globalink" or the "Company" ) , a special purpose acquisition company, announced today that on June 5, 2025, it caused to be deposited $0.15 per public share, totaling ...

Source: www.globenewswire.com
June 06, 2025 | 20:05:00
Category: News

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )

SAN FRANCISCO, June 06, 2025 ( GLOBE NEWSWIRE ) -- 89bio, Inc. ( the "Company" or "89bio" ) ( Nasdaq: ETNB ) , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today ...

Source: www.globenewswire.com
June 06, 2025 | 20:05:00
Category: News

© Natavest 2025 - 2026